Company: TXG
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001770787-25-000018
Chunk: 59

Company: 10x Genomics, Inc.
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 59
---
 Financial Officer(4)      |     |      |     | 2024 |     |         |     |        | 311,795 |     |         |     | — |       |     |           |     |                     | 2,726,082 |     |           |     |        | — |     |         |     |                |       — |     |        |     | — |              |     |            |     | 3,037,877 |       |
|                                        |     | 2023 |     |      |     | 413,963 |     |        |         |     |       — |     |   |       |     | 1,862,710 |     |                     |           |     |   856,832 |     |        |   |     | 173,445 |     |                |         |     |      — |     |   |              |     |  3,306,950 |     |           |       |
|                                        |     | 2022 |     |      |     | 394,250 |     |        |         |     | 141,657 |     |   |       |     | 3,131,588 |     |                     |           |     | 3,174,835 |     |        |   |     |       — |     |                |         |     |      — |     |   |              |     |  6,842,330 |     |           |       |

(1) The amounts shown represent the base salaries earned by our NEOs in fiscal years 2022, 2023 and 2024. Other than in the case of Mr. Taich, who joined the company effective August 12, 2024, the base salaries of our NEOs were increased as described above effective April 1, 2024.

(2) The amounts shown for 2024 represent the grant date fair value of (a) the RSU awards granted to our NEOs in fiscal year 2024 and (b) the performance RSU ("PSU") awards granted to our NEOs in fiscal year 2024, as computed in accordance with FASB ASC Topic 718, excluding the effect of estimated forfeitures. For a discussion of valuation assumptions used to determine the grant date fair value of the equity awards granted to our NEOs in fiscal year 2024, see Note 9 of Notes to our Consolidated Financial Statements